Sequana Medical NV
XBRU:SEQUA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bharat Forge Ltd
NSE:BHARATFORG
|
IN |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (16.4), the stock would be worth €-4.56 (1 019% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -1.8 | €0.5 |
0%
|
| Industry Average | 16.4 | €-4.56 |
-1 019%
|
| Country Average | 12 | €-3.34 |
-774%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| BE |
|
Sequana Medical NV
XBRU:SEQUA
|
38.1m EUR | -1.8 | -0.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
168.1B USD | 17.7 | 26.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
166.6B USD | 53 | 58.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
131.3B USD | 28.2 | 40.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.6B USD | 17.9 | 24 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
95.3B USD | 23.1 | 32.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.9B EUR | 16.8 | 20.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47B USD | 27 | 43.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47B USD | 40 | 44.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.1B USD | 18.1 | 25.7 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
34B USD | 19.7 | 16.3 |
Market Distribution
| Min | 2 |
| 30th Percentile | 7.1 |
| Median | 12 |
| 70th Percentile | 17.3 |
| Max | 1 030 |
Other Multiples
Sequana Medical NV
Glance View
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
